This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Axon Neuroscience Se. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Peter Filipcik: Innovator in Neurodegenerative Research
Introduction
Peter Filipcik is a prominent inventor based in Bratislava, Slovakia. He has made significant contributions to the field of neurodegenerative research, particularly in the study of Alzheimer's Disease. With a total of 2 patents, his work focuses on developing innovative models for understanding and treating neurodegenerative disorders.
Latest Patents
Filipcik's latest patents include groundbreaking inventions related to transgenic animals expressing Alzheimer's tau protein. These inventions provide transgenic non-human animals and mammalian somatic and germ cells that harbor a human DNA sequence encoding Alzheimer's Disease-derived tau protein. This capability allows for the induction of Alzheimer's pathology in transgenic animals. The tau protein is expressed on specific genetic backgrounds, enabling the simulation of various human diseases, including hypertension, diabetes, and hypercholesterolemia, which are significant risk factors for Alzheimer's development. The transgenic animals and cells exhibit neurofibrillary pathology and serve as valuable in vivo and in vitro assay systems for screening and developing therapeutic and preventive substances, as well as diagnostic markers for tauopathies and Alzheimer's Disease.
Career Highlights
Peter Filipcik is currently associated with Axon Neuroscience SE, where he continues to advance his research in neurodegenerative diseases. His work has been instrumental in providing insights into the mechanisms of Alzheimer's Disease and developing potential therapeutic strategies.
Collaborations
Filipcik collaborates with Eva Kontsekovà, contributing to the advancement of research in the field of neurodegeneration.
Conclusion
Peter Filipcik's innovative work in the field of neurodegenerative research, particularly through his patents on transgenic animals, highlights his commitment to understanding and combating Alzheimer's Disease. His contributions are paving the way for future advancements in therapeutic and diagnostic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile